Qianqian Xu1, Xu Tong1, Muhan Lin2, Xiaoming Chen2, Ahmed ElDib2, Teh Lin2, Lili Chen2, C-M Charlie Ma3. 1. Radiation Oncology Department, 3rd Affiliated Hospital of Qiqihar Medical University, Qiqihar, China. 2. Radiation Oncology Department, Fox Chase Cancer Center, Philadelphia, PA, United States. 3. Radiation Oncology Department, Fox Chase Cancer Center, Philadelphia, PA, United States. Electronic address: Charlie.Ma@fccc.edu.
Abstract
OBJECTIVE: This work investigates the time and frequency to observe fiducial markers in MLC-modulated fields during intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) beam delivery for real-time prostate localization. METHODS: Thirty seven prostate patients treated with IMRT or VMAT were included in this retrospective study. DRR images were generated for all MLC segments/control points using the TPS. The MLC leaf pattern of each control point was overlaid on the DRR, and the number of fiducials within the MLC opening was analyzed. EPID images of fiducials in a pelvic phantom were obtained to demonstrate the fiducial visibility during modulated beam delivery. RESULTS: Gold fiducials were visible on EPID images. The probability of seeing a number of fiducials within the MLC opening was analyzed. At least one fiducial was visible during 42 ± 2% and 52 ± 2% beam-on time for IMRT of the prostate with and without lymph nodes, and during 81 ± 4% and 80 ± 5% beam-on time for VMAT of the prostate with and without lymph nodes, respectively. The mean time interval to observe at least one fiducial was 8.4 ± 0.7 and 5.9 ± 0.5 s for IMRT of the prostate with and without the lymph nodes, respectively, and 1.6 ± 0.1 s for VMAT prostate patients. The estimated potential dosimetric uncertainty was 7% and 2% for IMRT and VMAT, respectively. CONCLUSIONS: Our results demonstrated that the time and frequency to observe fiducial markers in MLC-modulated fields during IMRT/VMAT beam delivery were adequate for real-time prostate localization. The beam's eye view fiducial positions could be used for intrafractional target monitoring and motion correction in prostate radiotherapy.
OBJECTIVE: This work investigates the time and frequency to observe fiducial markers in MLC-modulated fields during intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) beam delivery for real-time prostate localization. METHODS: Thirty seven prostate patients treated with IMRT or VMAT were included in this retrospective study. DRR images were generated for all MLC segments/control points using the TPS. The MLC leaf pattern of each control point was overlaid on the DRR, and the number of fiducials within the MLC opening was analyzed. EPID images of fiducials in a pelvic phantom were obtained to demonstrate the fiducial visibility during modulated beam delivery. RESULTS: Gold fiducials were visible on EPID images. The probability of seeing a number of fiducials within the MLC opening was analyzed. At least one fiducial was visible during 42 ± 2% and 52 ± 2% beam-on time for IMRT of the prostate with and without lymph nodes, and during 81 ± 4% and 80 ± 5% beam-on time for VMAT of the prostate with and without lymph nodes, respectively. The mean time interval to observe at least one fiducial was 8.4 ± 0.7 and 5.9 ± 0.5 s for IMRT of the prostate with and without the lymph nodes, respectively, and 1.6 ± 0.1 s for VMAT prostatepatients. The estimated potential dosimetric uncertainty was 7% and 2% for IMRT and VMAT, respectively. CONCLUSIONS: Our results demonstrated that the time and frequency to observe fiducial markers in MLC-modulated fields during IMRT/VMAT beam delivery were adequate for real-time prostate localization. The beam's eye view fiducial positions could be used for intrafractional target monitoring and motion correction in prostate radiotherapy.
Authors: Brandon M Barney; R Jeffrey Lee; Diana Handrahan; Keith T Welsh; J Taylor Cook; William T Sause Journal: Int J Radiat Oncol Biol Phys Date: 2010-09-23 Impact factor: 7.038
Authors: William C Jackson; Robert T Dess; Dale W Litzenberg; Pin Li; Matthew Schipper; Seth A Rosenthal; Garrick C Chang; Eric M Horwitz; Robert A Price; Jeff M Michalski; Hiram A Gay; John T Wei; Mary Feng; Felix Y Feng; Howard M Sandler; Robert E Wallace; Daniel E Spratt; Daniel A Hamstra Journal: Pract Radiat Oncol Date: 2017-08-16
Authors: Robert M Meier; Daniel A Bloch; Cristian Cotrutz; Alan C Beckman; George T Henning; Shermian A Woodhouse; Shirnett K Williamson; Najeeb Mohideen; John J Dombrowski; Robert L Hong; David G Brachman; Patrick W Linson; Irving D Kaplan Journal: Int J Radiat Oncol Biol Phys Date: 2018-06-01 Impact factor: 7.038
Authors: Per R Poulsen; Jesper Carl; Jane Nielsen; Martin S Nielsen; Jakob B Thomsen; Henrik K Jensen; Benedict Kjærgaard; Peter R Zepernick; Esben Worm; Walther Fledelius; Byungchul Cho; Amit Sawant; Dan Ruan; Paul J Keall Journal: Int J Radiat Oncol Biol Phys Date: 2011-05-24 Impact factor: 7.038
Authors: Jin Sheng Li; Lihui Jin; Alan Pollack; Eric M Horwitz; Mark K Buyyounouski; Robert A Price; Chang-Ming Ma Journal: Int J Radiat Oncol Biol Phys Date: 2009-10-14 Impact factor: 7.038
Authors: Alexis N T J Kotte; Pieter Hofman; Jan J W Lagendijk; Marco van Vulpen; Uulke A van der Heide Journal: Int J Radiat Oncol Biol Phys Date: 2007-05-21 Impact factor: 7.038